Correction From ALARIS Medical Inc.SAN DIEGO--(BUSINESS WIRE)--July 1, 1998--ALARIS Medical Inc. (Nasdaq:ALRS ALRS Admiralty List of Radio Signals ALRS Alerting Service (aviation) ALRS Apache Leap Research Site ALRS Alternate Launch & Recovery Surface ALRS Automated Logistics Retrieval System ALRS Automatic Line Router Switch ) Wednesday clarified a statement provided to analysts during a conference call regarding the company's acquisition of Instromedix Inc., announced in a news release last week. ALARIS Medical had discussed its understanding of EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) A metric used to show a company's profitability, but not its cash flow. EBITDA became popular in the 1980s to show the potential profitability of leveraged buyouts, but has become for Instromedix as running "around 30%." The company had intended to say "about 13%" for the first full year post merger. ALARIS Medical, through its operating company operating company A business that engages in transactions with outsiders. , ALARIS Medical Systems Inc., is known for its IMED IMED International Medical Education Directory and IVAC IVAC Islington Voluntary Action Council (England, UK) IVAC Insert Valid Access Card (satellite TV hacking) IVAC International Video & Audio Convention IVAC Idle Air Control Valve brand names of intravenous infusion therapy systems. The company's principal line of business is the design, manufacture and marketing of intravenous infusion therapy products, periodic patient monitoring instruments and related disposables. ALARIS Medical's products are distributed to more than 120 countries worldwide. In addition to its San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. world headquarters and manufacturing facility, the company also operates manufacturing facilities in Creedmoor, N.C., Basingstoke, Hampshire, U.K., and Tijuana, Mexico. Additional information on ALARIS Medical can be found at www.alarismed.com. This news release contains forward-looking statements which are based largely upon the company's expectations for demand and acceptance of new and existing products, technologies and opportunities, regulatory approvals and market and industry segment growth. Actual results could vary materially from these expected results due to a variety of factors, including, without limitation, changes in the market, competition, government regulation and foreign operations. Such risk factors are detailed in the Securities and Exchange Commission filings of Advanced Medical Inc. including Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended Dec. 31, 1997, and the Registration Statement on Form S-4, as amended, of ALARIS Medical Systems Inc., IVAC Overseas Holdings Inc. and IMED International Trading Corp., dated Sept. 9, 1997.
CONTACT: ALARIS Medical Inc., San Diego
Barbara Burkett, 619/458-7038
or
Financial Relations Board
Stacy Roughan (general info)
Moira Conlon/Lisa Baker (investors/analysts)
Michaelle Burstin (media)
310/442-0599
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion